Iran, Islamic Republic of - Patent Applications 1993
Iran, Islamic Republic of's patent applications was 278 in 1993, increased +53 from 225 in 1992. This was the 42nd highest globally.
| Rank | Country | Value | YoY |
|---|---|---|---|
| 1st | Japan | 332,345 | -1.7% |
| 2nd | United States | 99,955 | 8.1% |
| 3rd | Germany | 34,752 | 2.5% |
| 4th | Russian Federation | 28,503 | -27.8% |
| 5th | Korea | 21,449 | 34.5% |
| 6th | United Kingdom | 18,727 | -0.6% |
| 7th | France | 12,638 | 0.8% |
| 8th | China | 12,084 | 20.6% |
| 9th | Ukraine | 8,687 | 2,711.3% |
| 10th | Italy | 7,493 | -1.0% |
| 11th | Sweden | 3,760 | 14.3% |
| 12th | Canada | 3,623 | 29.1% |
| 13th | Kazakhstan | 3,223 | 644.3% |
| 14th | Switzerland | 2,999 | -2.2% |
| 15th | Poland | 2,659 | -8.0% |
| 16th | Brazil | 2,429 | 15.7% |
| 17th | Austria | 2,190 | 3.4% |
| 18th | Finland | 2,166 | 5.6% |
| 19th | Spain | 2,165 | 4.3% |
| 20th | Uzbekistan | 2,136 | - |
| 21st | Netherlands | 1,733 | -1.1% |
| 22nd | Australia | 1,663 | -1.9% |
| 23rd | Romania | 1,414 | -3.0% |
| 24th | Israel | 1,318 | -5.9% |
| 25th | New Zealand | 1,236 | 19.9% |
| 26th | India | 1,209 | -3.1% |
| 27th | Denmark | 1,159 | -3.7% |
| 28th | Hungary | 1,139 | -23.9% |
| 29th | Norway | 1,031 | 9.6% |
| 30th | South Africa | 904 | 1.8% |
| 31st | Czechia | 893 | - |
| 32nd | Belarus | 828 | - |
| 33rd | Belgium | 809 | 19.9% |
| 34th | Argentina | 787 | 56.5% |
| 35th | Mexico | 553 | -2.1% |
| 36th | Croatia | 503 | 5.0% |
| 37th | Georgia | 502 | 37.5% |
| 38th | Lithuania | 413 | 208.2% |
| 39th | Bulgaria | 412 | 25.2% |
| 40th | Egypt, Arab Republic of | 328 | 9.0% |
| 41st | Slovak Republic | 282 | - |
| 42nd | Iran, Islamic Republic of | 278 | 23.6% |
| 43rd | Slovenia | 277 | 47.3% |
| 44th | Greece | 221 | -0.5% |
| 45th | Malaysia | 198 | 31.1% |
| 46th | Armenia | 184 | - |
| 47th | Philippines | 178 | 33.8% |
| 48th | Türkiye | 169 | -10.6% |
| 49th | Iraq | 164 | 10.1% |
| 50th | Chile | 155 | -12.9% |
| 51st | Latvia | 155 | 112.3% |
| 52nd | Colombia | 138 | 15.0% |
| 53rd | Thailand | 110 | 64.2% |
| 54th | Portugal | 88 | 27.5% |
| 55th | Syrian Arab Republic | 82 | 54.7% |
| 56th | North Macedonia | 78 | - |
| 57th | Luxembourg | 73 | 40.4% |
| 58th | Moldova | 67 | - |
| 59th | Mongolia | 55 | 111.5% |
| 60th | Sri Lanka | 49 | 36.1% |
| 61st | Zimbabwe | 44 | 4.8% |
| 62nd | Morocco | 42 | -23.6% |
| 63rd | Tunisia | 42 | 90.9% |
| 64th | Guatemala | 40 | 48.1% |
| 65th | Indonesia | 38 | -43.3% |
| 66th | Bangladesh | 36 | -50.0% |
| 67th | Iceland | 34 | 21.4% |
| 68th | Peru | 34 | 61.9% |
| 69th | Viet Nam | 32 | -5.9% |
| 70th | Paraguay | 30 | 50.0% |
| 71st | Trinidad and Tobago | 29 | 123.1% |
| 72nd | Uruguay | 29 | -25.6% |
| 73rd | Costa Rica | 27 | 50.0% |
| 74th | Bolivia, Plurinational State of | 26 | 420.0% |
| 75th | Ecuador | 21 | -8.7% |
| 76th | Saudi Arabia | 21 | 0.0% |
| 77th | Panama | 20 | 11.1% |
| 78th | Pakistan | 19 | 11.8% |
| 79th | Libya | 15 | -40.0% |
| 80th | Kenya | 14 | 75.0% |
| 81st | Liberia | 14 | 133.3% |
| 82nd | Namibia | 13 | 333.3% |
| 83rd | Monaco | 10 | 11.1% |
| 84th | El Salvador | 10 | -9.1% |
| 85th | Hong Kong SAR, China | 9 | -18.2% |
| 86th | Jamaica | 9 | 50.0% |
| 87th | Algeria | 8 | -20.0% |
| 88th | Malta | 8 | 166.7% |
| 89th | Nepal | 6 | 500.0% |
| 90th | Tajikistan | 5 | - |
| 91st | Zambia | 4 | -42.9% |
| 92nd | Malawi | 3 | 50.0% |
| 93rd | Mauritius | 2 | 0.0% |
| 94th | Nicaragua | 2 | -33.3% |
| 95th | Cuba | 1 | 0.0% |
FAQ
Iran, Islamic Republic of's patent applications in 1993 was 278. This ranked 42nd globally.
Iran, Islamic Republic of's patent applications increased by 23.6% in 1993 compared to 1992.
Japan had the highest patent applications in 1993 at 332,345.
The patent applications of Iran, Islamic Republic of in 1993 was 278. This ranked 42nd globally.
Iran, Islamic Republic of's patent applications went from 225 in 1992 to 278 in 1993, a 23.6% increase.
Iran, Islamic Republic of matched the Stagflation Risk pattern in 1993. Historically: 307 occurrences, 117 successful (38%). Outcome 24 months later: 49.7%. View full analysis →